He X - Search Results

1

PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation.

Zhou F, Du F, Wang Z, Xue M, Wu D, Chen S, He X. Zhou F, et al. Among authors: he x. J Hematol Oncol. 2024 May 20;17(1):34. doi: 10.1186/s13045-024-01557-2. J Hematol Oncol. 2024. PMID: 38764055 Free PMC article.

2

Extramedullary relapse following allogeneic BMT in a postpartum female patient with acute lymphoblastic leukemia.

He X, Wu D, Sun A. He X, et al. Bone Marrow Transplant. 2012 Apr;47(4):598-9. doi: 10.1038/bmt.2011.123. Epub 2011 Jul 4. Bone Marrow Transplant. 2012. PMID: 21725371 No abstract available.

3

[IAG regimen for patients with refractory/relapsed acute myeloid leukemia].

Yang Y, Ji CF, Zhang YM, Liu LM, He GS, Jin ZM, Ma X, Xue SL, He XF, Wu DP, Sun AN. Yang Y, et al. Among authors: he xf, he gs. Zhonghua Xue Ye Xue Za Zhi. 2013 Jul;34(7):637-8. doi: 10.3760/cma.j.issn.0253-2727.2013.07.020. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23906465 Chinese. No abstract available.

4

[Hotsport report of the 55th American Society of Hematology Annual Meeting: chronic myeloid leukemia].

He X, Wu D. He X, et al. Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):183-4. doi: 10.3760/cma.j.issn.0253-2727.2014.02.029. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24606668 Chinese. No abstract available.

5

[Clinical and laboratory characteristics of 12 Ph/BCR-ABL positive acute myeloid leukemia patients].

Cai W, He X, Chen S, Sun A, He J, Zhu M, Wu D. Cai W, et al. Among authors: he x, he j. Zhonghua Xue Ye Xue Za Zhi. 2015 May;36(5):398-402. doi: 10.3760/cma.j.issn.0253-2727.2015.05.010. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26031527 Free PMC article. Chinese.

6

Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.

Liu D, Zhang Y, Chen S, Pan J, He X, Liang J, Chen Z. Liu D, et al. Among authors: he x. Cancer Genet. 2015 Jun;208(6):333-40. doi: 10.1016/j.cancergen.2015.03.013. Epub 2015 Apr 9. Cancer Genet. 2015. PMID: 26032184

7

Deep molecular responses achieved in chronic myeloid leukemia in chronic phase patients with BCR-ABL1 >10% at 3 months who are early switched to nilotinib.

Yue Y, Gui X, He X, Chen Y, Pan J, Qiu H, Wu D, Chen S, Guo L, Cen J. Yue Y, et al. Among authors: he x. Hematology. 2016 May;21(4):213-7. doi: 10.1179/1607845415Y.0000000034. Epub 2015 Jul 17. Hematology. 2016. PMID: 26183593 Free article.

8

Predictive value of high EVI1 expression in AML patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation in first CR.

He X, Wang Q, Cen J, Qiu H, Sun A, Chen S, Wu D. He X, et al. Bone Marrow Transplant. 2016 Jul;51(7):921-7. doi: 10.1038/bmt.2016.71. Epub 2016 Apr 4. Bone Marrow Transplant. 2016. PMID: 27042849

9

[EVI1 expression, clinical and cytogenetical characteristics in 447 patients with acute myeloid leukemia].

He XF, Wang QR, Cen JN, Qiu HY, Sun AN, Chen SN, Wu DP. He XF, et al. Zhonghua Xue Ye Xue Za Zhi. 2016 Nov 14;37(11):936-941. doi: 10.3760/cma.j.issn.0253-2727.2016.11.002. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27995876 Free PMC article. Chinese.

10

[Clinical and genetic features of a patient with myeloid neoplasm in association with PDGFRA and EVI1 gene rearrangements].

Han W, Chao H, Zhou M, Cen L, Chen S, He X, Lu X. Han W, et al. Among authors: he x. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017 Feb 10;34(1):93-97. doi: 10.3760/cma.j.issn.1003-9406.2017.01.022. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017. PMID: 28186604 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,214 results

Search Page

Filters